Kimelman & Baird, LLC Viatris Inc Transaction History
Kimelman & Baird, LLC
- $1.25 Trillion
- Q3 2024
A detailed history of Kimelman & Baird, LLC transactions in Viatris Inc stock. As of the latest transaction made, Kimelman & Baird, LLC holds 1,301 shares of VTRS stock, worth $17,381. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,301
Previous 1,301
-0.0%
Holding current value
$17,381
Previous $13.8 Million
9.22%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VTRS
# of Institutions
1,104Shares Held
934MCall Options Held
2.71MPut Options Held
2.4M-
Vanguard Group Inc Valley Forge, PA141MShares$1.88 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.24 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$843 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$837 Million4.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$652 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $16.2B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...